
Advertise on podcast: ACR on Air
Rating
4.9from
This podcast has
157 episodes
Language
EnglishPublisher
American College of RheumatologyExplicit
No
Date created
2019/07/16
Latest episode
2026/11/09
Average duration
44 min.
Release period
12 days
Description
As the official podcast of the American College of Rheumatology (ACR), ACR on Air seeks to have informative and engaging conversations rheumatology professionals want to hear – ranging in topic from trends in clinical practice, to issues affecting rheumatology professionals, and the changing landscape of the rheumatology field. Tune in twice a month for engaging interviews and commentary.
Unlock ACR on Air podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from ACR on Air podcast
AI Development in Clinical Care: Promises and Pitfalls
2026/11/09
AI is already transforming medicine, but does that mean every new capability will translate into better patient care? As ACR Convergence 2026 continues this week, we spotlight Dr. Mujeeb Basit's talk, "AI Development in Clinical Care: Promises and Pitfalls," which took place Saturday, November 7. In this episode, we explore what it takes to integrate AI into clinical practice safely, effectively, and responsibly, how these technologies may fundamentally change the way we care for patients, and what happens when AI begins to outperform physicians at tasks they have spent years mastering. As AI reshapes the future of medicine, we ask a bigger question: Will we need to rethink what it means to be a physician?
Thriving at Every Stage: The Power of Lifestyle Medicine
2026/11/08
Our coverage of ACR Convergence 2026 continues with a conversation about moving beyond "Treat to Target" toward "Treat to Thrive." While measuring disease activity, adjusting medications, and aiming for remission are essential parts of rheumatoid arthritis care, what happens when inflammation is under control but patients still don't feel well? In this episode, we explore why controlling inflammation isn't always enough, what it truly means for patients to thrive, and how patients and healthcare providers can strengthen their partnership to improve both disease outcomes and quality of life. Join us as we discuss a more holistic, collaborative approach to integrative arthritis care that puts the whole person at the center
Partnership Tool: Treat to TARGET, Treat to Thrive - Shared Resource Drive
Dysfunction Mitochondria in Myositis-Driven Inflammation
2026/11/07
As part of our special coverage of ACR Convergence 2026, we're joined by Christian Lood from the University of Washington to explore a surprising role mitochondrion may play in myositis. Long known as the powerhouse of the cell, mitochondria may do more than simply respond to inflammation. When damaged, they can release contents that trigger the immune system and potentially fuel inflammation. We discuss how mitochondria escape from injured muscle, their potential as markers of disease activity, and whether understanding these processes could lead to new treatments for juvenile dermatomyositis (JDM). Christian will present his talk, "Dysfunctional Mitochondria in Myositis-Driven Inflammation," on Sunday, November 8, at ACR Convergence 2026
Direct Specialty Clinical Care Model
2026/11/03
What is the "Direct Specialty Clinical Care Model" and is it a viable option for clinical rheumatologists in today's medical ecosphere? Dr. Diana Girnita, founder and CEO of Rheumatologists OnCall, joins us to speak on what motivated her to pioneer this clinical approach, how she empowers her patients by putting the cost of care directly in their hands, her thoughts on the financial viability of this model in the near future and how she manages the daily responsibilities facing every clinician, like: dealing with insurance companies, billing, managing referrals, telemedicine and more!
ACR Convergence 2026 Preview
2026/10/20
Join us as we explore what's new and exciting at ACR Convergence, the premier gathering for rheumatology science and innovation. Dr. Gregory Gardner, Chair of the Annual Meeting Planning Committee, shares a preview of this year's meeting, including emerging treatments like cellular therapy, hands-on workshops, and the science that could change clinical practice. We discuss the sessions you won't want to miss and offer tips for making the most of your time at the meeting, both inside and outside the conference room
How I Evaluate Raynaud's Disease
2026/10/06
When is Raynaud's phenomenon truly a disease? Dr. Robert Spiera joins us to discuss the key clinical clues, the value of patient photos and nail fold capillary findings, and how to approach a positive ANA without a defined connective tissue disease. We review treatment options from warming strategies and medication review to calcium channel blockers, PDE-5 inhibitors, prostaglandins, and digital sympathectomy and highlight the finding that demands urgent attention: a painful, persistently blanched digit. Most importantly, we discuss the balance between treating serious vascular disease and avoiding unnecessary medicalization of a common phenomenon.
How I Treat & Evaluate ILD
2026/09/22
Interstitial Lung Disease (ILD) is difficult to diagnose and treat. At first, the disease could look like a variety of other disorders, such as fibrosis or autoimmunity. Once a diagnosis is made, a decision on how aggressively to treat it can mean the difference between irreversible lung damage or overly impacting your patient's quality of life. We caught up with Dr. Robert Hallowell, a Pulmonary and Critical Care physician at the Massachusetts General Hospital and Director of the Interstitial Lung Disease Program at the Pulmonary Ambulatory Clinic. Dr. Hallowell tells us how he evaluates ILD
JIA, A Family's Perspective
2026/09/08
September is Rheumatic Disease Awareness Month (RDAM), and today we're sharing the story of Deborah Talbot, an occupational therapist from the Children's Hospital of Philadelphia and her daughter, Molly, who was diagnosed with Juvenile Idiopathic Arthritis (JIA) at the age of 12 years old. When an ankle injury turned out to be far more, Molly endured months of pain, swelling, repeated evaluations and the uncertainty of not understanding why she wasn't getting better. This is the story of how a family came together to fight through pain, discover a disease, find remission that would remain for years and start advocacy for those without the resources they were blessed with, emerging triumphant in the face of overwhelming adversity
Can We Prevent Rheumatoid Arthritis?
2026/08/25
Rheumatoid arthritis may begin years before the first swollen joint appears, with autoantibodies circulating long before a clinical diagnosis is made. In this episode, we explore what happens during this critical preclinical phase and whether RA can be prevented before it starts. Dr. Kevin Dean, director of the Autoimmune Disease Prevention Center at the University of Colorado Anschutz, joins us to discuss what a positive CCP antibody really means, where RA may originate, lessons from the STOP-RA trial, whether we should screen people at risk, and how clinicians should counsel patients who test positive for CCP antibodies.
The 2026 Adult/Juvenile Spondyloarthritis Guidelines
2026/08/11
The new clinical guidelines for juvenile and adult axial spondyloarthritis (axSpA), developed collaboratively by the American College of Rheumatology (ACR), the Spondylitis Association of America (SAA), and the Spondyloarthritis Research and Treatment Network (SPARTAN), mark an important evolution in the management of this complex disease. In this episode, Drs. Liron Caplan and Matthew Stoll discuss what's changed, why it matters, and how these recommendations can guide everyday clinical practice—from the first-ever juvenile axSpA guideline and the unified approach to radiographic and non-radiographic disease, to practical decisions around MRI use, first-line therapies, biologic selection, treatment failure, and physical activity.
2026 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Axial Spondyloarthritis in Adults and Children/Adolescents
Still's Disease and Hyperinflammation
2026/07/28
In this episode, Dr. Randy Q. Cron discusses hyperinflammation and Macrophage Activation Syndrome (MAS), one of the most serious complications of Still's disease. Because MAS can mimic infection, sepsis, malignancy, or a disease flare, early recognition is critical—and treatment often must begin before every diagnostic criterion is met. We explore the clinical patterns and laboratory findings that matter most, how to interpret ferritin, and how to make timely decisions when multiple diagnoses may exist at once.
Understanding Haploinsufficiency of A20
2026/07/14
What if some patients who never quite fit their diagnosis actually have an underlying genetic disorder? In this episode, we explore Haploinsufficiency of A20 (HA20), a condition first described less than a decade ago that is already reshaping our understanding of autoinflammation, autoimmunity, and immune dysregulation. How many patients in our clinics have a genetic diagnosis we've never thought to consider? Join us as we discuss this emerging disease and its clinical implications with Dr. Daniella M. Schwartz.
Chronic Inflammatory Calcium Pyrophosphate Arthritis
2026/06/30
Could chronic inflammatory calcium pyrophosphate deposition disease (CPPD) be hiding in plain sight? In this episode, we explore why CPPD may be far more common than previously recognized, how it can masquerade as conditions such as refractory inflammatory arthritis, polymyalgia rheumatica, and erosive osteoarthritis, and why it is so often overlooked in clinical practice. We discuss the growing role of musculoskeletal ultrasound in diagnosis and disease management, the structural damage associated with chronic CPPD, and where the field may be headed as researchers pursue more effective treatment strategies.
2026 ACR JIA Guidelines: What Clinicians Need to Know
2026/06/16
The 2026 ACR Guidelines for Juvenile Idiopathic Arthritis (JIA) are here, and lead author Dr. Karen Onel joins us to unpack the key updates shaping pediatric rheumatology care. From a biologics-first approach in systemic JIA to more individualized treatment pathways for non-systemic disease, the new recommendations emphasize earlier intervention, faster treatment tailoring, and risk-based decision-making. Dr. Onel also discusses the guidelines' broader focus on mental health, physical activity, rehabilitation, and the challenges of growing up with a chronic illness. More than an update to treatment algorithms, these guidelines reflect a fundamental shift in philosophy—one that puts the whole child, not just the diagnosis, at the center of care.
Cell Therapy in Rheumatology: CAR-T vs Regulatory T Cells
2026/06/02
In the future, can autoimmune disease become curable? A groundbreaking study from Germany suggests there may be a pathway in some cases. Patients with severe, treatment-refractory lupus who received CD19 CAR-T cell therapy have remained in drug-free remission for up to five years without ongoing immunosuppression. In this episode, we discuss how these findings are shifting the conversation from disease control to the possibility of cure, and what they could mean for lupus, inflammatory myopathies, systemic sclerosis, vasculitis, rheumatoid arthritis, and autoimmune diseases more broadly. We also explore CAR-T therapy, immune resets, regulatory T cells, relapse risk, and the future of rheumatology with Dr. Georg Schett.
Podcast reviews
Read ACR on Air podcast reviews
The Real Chris Fish 2026/09/22
Thanks for Making Rheumatology Home
I appreciate your thoughtfulness and kindness; your clear way of explaining topics & their importance; and the way you encourage people to learn from ...
LM24601 2024/08/14
The best
I listen to this show on my commute -- it's excellent. Dr Hausman asks the questions we all want to ask of these remarkable guests!!
Citk19 2024/08/04
Great podcast
Dr. Hausman is a fantastic podcast host. He uses a humble approach infused with curiosity that helps gain insight into the many challenges we face and...
DrDocko 2023/04/17
Emeritus Professor
I especially enjoy listening to the “young people” I have mentored
nxtrinh 2022/08/28
Highly recommend
Great topics/ guideline discussion for Rheumatologist. Many thanks Dr Haussmann, interviewers, and ACR support.
Rheum doc 2019/08/21
Awesome podcast
Finally! Great work by Dr. Hausmann.
Podcast sponsorship advertising
Start advertising on ACR on Air relevant audience podcasts
You may also like to advertise on these Podcasts

4.8265192000
Morning Wire
The Daily Wire

4.518808383
American Scandal
Audible

4.689571234
Get Sleepy: Sleep meditation and stories
Slumber Studios

4.79026375
Life is Short with Justin Long
Audible

4.714149353
Bad Friends
Bobby Lee & Andrew Santino

4.7133275
10 to Life
Annie Elise

4.76763467
Criminology
Emash Digital & Mike Ferguson, Mike Morford

4.87554989
The Dr. John Delony Show
Ramsey Network

4.512669676
RedHanded
RedHanded

4.959992000
Legal AF by MeidasTouch
MeidasTouch Network